Colorectal cancer screening differential costs for younger versus older Americans

American Journal of Preventive Medicine
Uri Ladabaum, Kathryn A Phillips

Abstract

Colorectal cancer (CRC) incidence rises with age, and most CRC arises from adenomatous polyps. It was therefore hypothesized that increased use of CRC screening and polypectomy in younger persons might yield CRC-related savings later in life for payers such as Medicare. Using a decision analytic Markov model, the impact of increased CRC screening uptake on healthcare payers for younger Americans versus payers for older Americans, such as Medicare, was projected. As screening uptake increased, CRC incidence and mortality decreased, and annual costs related to CRC care and testing increased for younger persons, but decreased for older persons. Compared with current screening uptake of 40%, screening 75% of the U.S. population aged 50 to 80 increased annual costs related to CRC care and testing from 3.6 billion US dollars to 5.0 billion US dollars for 50- to 64-year-olds, but decreased annual costs from 5.9 billion US dollars to 5.6 billion US dollars for those aged 65 years and older. Sensitivity analyses suggest that future costs for other diseases could offset CRC care savings in older Americans that are attributable to screening. However, even without net cost savings for any age group, screening remained relatively cost-effec...Continue Reading

References

May 1, 1979·Cancer·R R RickertJ M Frasca
Mar 15, 1992·The New England Journal of Medicine·J V SelbyN S Weiss
Aug 15, 1985·International Journal of Cancer. Journal International Du Cancer·J C ClarkJ G Simpson
Mar 15, 1995·Journal of the National Cancer Institute·S H TaplinP Nefcy
Oct 18, 2000·Annals of Internal Medicine·A SonnenbergJ M Inadomi
Oct 18, 2000·JAMA : the Journal of the American Medical Association·A L FrazierK M Kuntz
Nov 30, 2000·The New England Journal of Medicine·J S MandelL M Schuman
Mar 16, 2002·Clinical Endocrinology·P J Jenkins, P D Fairclough
Dec 23, 2003·Expert Review of Anticancer Therapy·Angel Ferrández, James A DiSario
Jun 30, 2004·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Uri LadabaumA Mark Fendrick
Jul 23, 2004·The New England Journal of Medicine·Deborah Schrag

❮ Previous
Next ❯

Citations

Aug 1, 2007·Journal of General Internal Medicine·Stephen G HenryRobert S Dittus
Jul 8, 2011·Journal for Healthcare Quality : Official Publication of the National Association for Healthcare Quality·Judy Ying ChenRichard S Chung
Aug 26, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Arthur HoffmanRalf Kiesslich
Jul 2, 2014·The American Journal of Gastroenterology·Uri LadabaumM Kate Bundorf
Oct 31, 2012·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Enzo MasciPier Alberto Testoni
Feb 26, 2009·Journal of Clinical Nursing·Ching-Ching SuBo-Jein Kuo
Jun 8, 2007·Cancer Treatment Reviews·Lara Maria Pasetto, Silvio Monfardini
Dec 19, 2012·The American Journal of Gastroenterology·Ravi N Sharaf, Uri Ladabaum
Jul 30, 2008·Journal of the American Geriatrics Society·Xiao ChenLaura C Seeff
Jun 17, 2014·World Journal of Gastrointestinal Endoscopy·Otto S Lin
Jun 13, 2015·Medical Care·Simon L GoedeLaura C Seeff
Jun 16, 2018·The American Journal of Gastroenterology·Uri LadabaumKate M Bundorf
Nov 11, 2019·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Paal JorangerEline Aas

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved